Skip to content

pharmaceutical research companies

Running a Study

Automate the Protocol with eSource

Hiding in plain sight – CRIO eSource is the biggest opportunity for sponsors. While the clinical research industry has automated many processes, there is one area that is still mostly paper-bound. This is the source of one of the greatest inefficiencies in research today. Automating this one process could drive 20% cost savings in a...

Running a Study

CRIO Reduces FDA Audit Risk by Over 70%

The FDA routinely audits clinical research sites, and some of those sites happened to use CRIO eSource on the studies in question. With our broad reach and history as the leading site-adopted eSource solution, we have now established a database of audit results that prove what we’ve known intuitively: CRIO eSource reduces audit risks for...

Running a Site

Never miss another re-consent: The benefits of an integrated eConsent-eSource solution

With the recent push toward Decentralized Clinical Trials (DCTs), many sponsors are adopting eConsent. eConsent allows patients to consent electronically, whether in clinic or remotely, from the convenience of their home. eConsent offers sponsors, CROs, investigators and patients these benefits: Reduce errors by ensuring completion of all fields Automated audit trails ensure accuracy of date-times...

Running a Study

Ask Me Anything – Hitting the Target with Good Study Design

Mary Brenner, MSN MArch RN, is CRIO’s Study Design Manager and brings deep-rooted expertise as a registered nurse to CRIO’s in-house study design team. In this quick Q&A, Mary shares the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and gives tips for designing it on your...

CRIO Company News

CRIO Welcomes Jonathan Andrus as President & COO

Company Strengths Executive Management Team with Senior Industry Expert BOSTON, MA – April 19, 2022 – Clinical Research IO (CRIO), a Boston-based technology firm streamlining clinical trials for sponsors, sites, and patients, announced that Jonathan Andrus will join as President and Chief Operating Officer. Working collaboratively with the CRIO senior team, Andrus will focus on...

Running a Study

COVID Leads to Pivotal Changes in Clinical Research Industry

Over the past four months, COVID has led to widespread changes across the clinical research industry, many of which will be carried forwards. 1. Changes in Clinical Trial Protocol & Design According to data collected by the Tufts Center for the Study of Drug Development (CSDD), as of May 20, 2020, more than half of...